Navigation Links
Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables
Date:6/1/2009

Data from Phase II/III Study Presented at Heart Failure Congress 2009 Demonstrate Promising Safety and Efficacy Results for Relaxin

SAN MATEO¿ Calif.¿ June 1 /PRNewswire/ -- Corthera Inc. today announced that the results and additional statistical analyses conducted from Pre-RELAX-AHF, the Phase II portion of a Phase II/III multicenter, randomized, double-blind, international study, showed that relaxin, the company's investigational drug for the treatment of acute heart failure (AHF), was the strongest independent predictor of improved longer-term outcomes following hospital discharge when compared to other variables.

The new analyses of predictors of 60-day and 180-day outcomes, which included univariate and multivariate regression analyses, were presented today by Marco Metra, M.D., professor of cardiology at the University of Brescia, Italy, and co-principal investigator of the Pre-RELAX-AHF study, during a late-breaking clinical trials session at the annual meeting of the Heart Failure Association of the European Society of Cardiology (HFA-ESC 2009) in Nice, France.

Several variables, including baseline patient characteristics, early improvement in dyspnea (breathlessness) to day five, physician-determined occurrence of worsening of heart failure (WHF) during hospitalization, increased serum creatinine during hospitalization and relaxin administration, were included in the model to determine the important predictors of the two outcome measures: 60-day cardiovascular (CV) death or re-admission for heart failure and 180-day CV death. In the 60-day multivariate analysis, relaxin treatment was the strongest predictor of less CV death or heart failure re-admission (p<0.01). Blood urea nitrogen (BUN) on admission (p=0.02) and WHF during hospitalization (p=0.02) were also significant predictors. Relaxin treatment was the only significant variable (p<0.01) in both the multivariate and univariate analyses predicting CV death at
'/>"/>

SOURCE Corthera Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014   Royal Philips (NYSE: ... its eCareCoordinator and eCareCompanion telehealth applications have received ... Administration (FDA). A part of Philips Hospital to ... and eCareCompanion are focused on patient care within ... to be available through the cloud-based digital health ...
(Date:10/1/2014)...  CVS Health is thanking its 26,000 pharmacists during ... the way health care is delivered to increase access, ... pharmacies, mail service pharmacies and specialty pharmacies nationwide.  ... to CVS Health to reflect our broader health care ... to shape the future of health," said Larry ...
(Date:9/30/2014)... Sept. 30, 2014 /CNW/ - Protecting the health and safety of ... Canada uses the appropriate powers and tools at its disposal to ... and quality standards. To that end, Health ... the import into Canada of all drug ... They are: , Apotex Pharmachem India Pvt Ltd ...
Breaking Medicine Technology:Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 3Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 4CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 2CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 3Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2
... 24 PulmoBioTech Inc. (OTC,Bulletin Board: PLMO) announced today ... that it will be investigating as part of the,Regulatory ... 1. Efficacy Binding Studies 2. Characterization of ... Pyrogenicity 5. Immunological Testing 6. Dosimetry ...
... PALO ALTO, Calif., April 24 CV Therapeutics,Inc. ... Committee for Medicinal,Products for Human Use (CHMP) of ... opinion recommending approval of ranolazine in the,European Union ... Following this positive recommendation from the CHMP, CV ...
Cached Medicine Technology:PulmoBioTech Announces Details of Its Regulatory Approval Experiments 2PulmoBioTech Announces Details of Its Regulatory Approval Experiments 3European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina 2European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina 3
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog post explaining ... , Senior citizens can purchase a joint life insurance ... A joint policy is cheaper, but will only pay ... Life insurance can be used to cover important funeral ... online, as the application process is simple and straightforward. ...
(Date:10/1/2014)... 01, 2014 Bedros Keuilian is not ... Camp fitness boot camps, he’s also considered the leading ... with sold out business summits, a line of high-demand ... to a recent Spike TV reality show to his ... is the time for personal trainers and fitness business ...
(Date:10/1/2014)... First Warning Systems, a pioneer in ... throughout the body, announced the company is changing its ... company’s breadth of upcoming product releases. The initial focus ... , “Our initial focus will be an ‘Internet of ... circadian cellular changes over time,” said Rob Royea, president ...
(Date:10/1/2014)... 01, 2014 T.E.N., a ... relationship-marketing firm, announced today the nominees vying ... Project of the Year Awards for North ... organizations in financial services, commercial, health care, ... endeavors that address key issues in the ...
(Date:10/1/2014)... Join the more than 80 golfers who already have ... charity golf tournament to benefit Project HEAL, a not-for-profit organization ... afford treatment. The tournament will be held Monday, Oct. 6, ... The day-long event starts with 10:30 a.m. check-in and shotgun ... begin at 5 p.m. and will include an auction featuring ...
Breaking Medicine News(10 mins):Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3
... science at high school has just become a little more ... from the University of Bath have found that a protein ... a cell divides in two. , In research published in ... shown that the protein is essential for building the microtubules ...
... of The Walter and Eliza Hall Institute, Professor Suzanne ... of the 2008 Thomson Scientific Citation Awards announced at ... Scientific, a US-based international information analysis company, states that ... that identifies the average number of citations per paper ...
... Heart Associations Los Angeles Division today will honor John ... in use around the country and one of the ... Harbor-UCLA Medical Center (LA BioMed). , The association will ... Criley and William Koenig, Los Angeles County Emergency Medical ...
... site heralds AAGL commitment to patient education, ... professional,organization of gynecologists interested in endoscopy and minimally,invasive ... and added a,comprehensive patient education section on ... to treat them. The site,continues to provide physician ...
... ... WHITE PLAINS, N.Y., April 3, 2008 Head lice is ... common,cold.(1) There are about 6 to 12 million cases each year,(2) ... days annually.(3),But, now parents can say good-bye to head lice and ...
... April 3, 2008 Mach One,Corporation, http://www.machonecorp.com, ... prior to large scale manufacturing of its ImmunoGam(TM),colostrum ... highly qualified scientist from BioQual spent a week ... technology transfer and,memorializing the protocols for manufacture of ...
Cached Medicine News:Health News:Mitosis gets harder thanks to new gene discovery 2Health News:Professor Suzanne Cory honored with national citation award 2Health News:Pioneer of paramedic model to be honored 2Health News:Pioneer of paramedic model to be honored 3Health News:Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL.org 2Health News:Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL.org 3Health News:Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL.org 4Health News:New Breakthrough Treatment is Tough On Lice But Gentle On Kids 2Health News:New Breakthrough Treatment is Tough On Lice But Gentle On Kids 3Health News:Mach One Corporation Announces Completion of Final Tests Prior to Full Scale Production 2
Suture Cutters, Straight...
Suture scissor...
Threaded cannula for use with Suretac® II, sterile packs, box of 10....
The Small Oval Cannula System is designed to be the smallest oval cannula system currently available, and is utilized with the Caspari Suture Punch System. Disposable seals are available with this sy...
Medicine Products: